Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Agbeyangi, A. O." wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Clinical Manifestations of Plasmodium berghei ANKA Infection in Juvenile Mice: A Short Case Report
Autorzy:
Ajayi, J. B.
Agbeyangi, A. O.
Daniel, A.
Omobolaji, I.
Mogaji, H. O.
Powiązania:
https://bibliotekanauki.pl/articles/1113684.pdf
Data publikacji:
2017
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
ECM
Juvenile
Malaria
Mice
Neonates
Plasmodium berghei
Opis:
Malaria is an important health and development challenge in Africa, Animal models most particularly mice, have long been employed to study malaria pathogenesis. This paper describes clinical manifestations due to Plasmodium berghei ANKA infection in juvenile mice as a model for understanding the complications of congenital malaria in neonates. Forty-five juvenile mice (5-7 days old) were acquired from University College Hospital, Ibadan and injected with 2×107 (0.2 ml) Plasmodium berghei ANKA parasitized red blood cells (PRBCs). The mice were then transported to the study site, kept in well-ventilated cages and fed daily with a balanced ration. Post-P. berghei infection, the mice were monitored daily for mortality. Clinical manifestations of experimental cerebral malaria (ECM) were assessed and confirmed if at least ruffled fur, hunching, wobbly gait, limb paralysis, convulsions, or coma was observed. Each sign was given a score of 1. Animals with scores ≥4 were considered to have severe ECM. In the experiment, 20 (44%) mice were lost due to natural cause (i.e. stress) at day 2. Between day 4 and 9, 25 (56%) of the study mice presented clinical signs of ECM. This included: ruffled fur – 25 (100%), hunching - 21 (84%), wobbly gait - 17 (68%), limb paralysis - 20 (80%), convulsions - 25 (100%). Survival rate and severity of ECM in the mice differs, 22 (88.0%) had severe ECM and 3 (12.0%) had mild ECM. This study has shown that parasite establishment and malaria complications can manifest as early as 4 days’ post P. berghei infection in 5-7 days old mice.
Źródło:
World News of Natural Sciences; 2017, 14; 90-96
2543-5426
Pojawia się w:
World News of Natural Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Knowledge Attitude and Practices of Caregivers on Management and Treatment of Childhood Malaria in Ogun State, South-Western Nigeria
Autorzy:
Agbeyangi, O. A.
Sam-Wobo, S. O.
Ekpo, U. F.
Akinloye, O. A.
Mafiana, C. F.
Ajayi, J. B.
Powiązania:
https://bibliotekanauki.pl/articles/1179169.pdf
Data publikacji:
2017
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
Ogun State
South-western Nigeria
home management of malaria
treatment seeking behaviours
Opis:
Home management of malaria involves presumptively treating febrile children at clinic or near home with antimalarial drugs distributed by trained members of the community provide medications and educate primary caregivers about treatment of malaria and recognition of severe illness. Structured questionnaires were administered to the parents, health workers and patent medicine vendors to determine acceptability of rectal artesunate and treatment seeking behaviours. Data obtained were analyzed using SPSS version 20 to assess association with p-value of < 0.05. Current first line antimalarial drug for treating childhood malaria at the PHCs was artesunate derivatives (90.3%) with no usage of chloroquine derivatives (0%) and common route of administration was intra-muscular (81.4%) with least usage of rectal (6.2%). Patent medicine vendors showed that the common drug derivatives purchase for treating childhood malaria was chloroquine derivatives (89.2%) with oral (91.9%) as most common route of administration and no awareness of rectal route (0%). Cases of resistance of malaria parasites to anti-malarial drugs, mostly chloroquine derivatives (89.3%) and least with artesunate derivatives (7.1%) observed by health workers. Incomplete dosage (95.6%) and fake drug (84.9%) were described as main factors responsible for malaria parasite resistance. Patent medicine vendors have come across cases of resistance of malaria parasites to anti-malarial drugs mostly chloroquine derivatives (93.2%) with drug abuse (89.2%) and fake drug (82.4%). Treatment of malaria is challenged by inadequate health-care infrastructure and community-based interventions.
Źródło:
World Scientific News; 2017, 83; 62-74
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies